Christiane Schönfeld

Title: Christiane Schönfeld: Innovator in Chimeric Antigen Receptors

Introduction

Christiane Schönfeld is a prominent inventor based in Langen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors. With a total of 2 patents, her work focuses on creating innovative solutions for cancer treatment.

Latest Patents

Her latest patents include advancements in chimeric antigen receptors with an optimized hinge region. These multi-functional proteins consist of a signal peptide, a target-specific recognition domain, a linker region, and an effector domain. The invention also encompasses nucleic acids encoding these proteins, expression constructs for host cell expression, and the host cells themselves. The proteins developed are designed to generate target-specific effector cells, making them suitable for use as a medicament, particularly in cancer treatment and adoptive, target-cell specific immunotherapy.

Career Highlights

Christiane Schönfeld has worked with notable organizations, including the Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus. Her expertise in the field has allowed her to contribute to significant research and development projects aimed at improving therapeutic strategies.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Kurt Schönfeld and Winfried Wels. These partnerships have further enhanced her research and innovation capabilities.

Conclusion

Christiane Schönfeld's work in the development of chimeric antigen receptors represents a vital advancement in cancer therapy. Her contributions continue to influence the field of biotechnology and offer hope for improved treatment options.